Amedeo Smart

Free Medical Literature Service


 

Amedeo

Autoimmune Disorders

  Free Subscription

Articles published in
Brain
    January 2024
  1. HERRANZ E, Treaba CA, Barletta VT, Mehndiratta A, et al
    Characterization of cortico-meningeal translocator protein expression in multiple sclerosis.
    Brain. 2024 Jan 30:awae030. doi: 10.1093.
    >> Share

  2. LAZZAROTTO A, Hamzaoui M, Tonietto M, Dubessy AL, et al
    Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosis.
    Brain. 2024 Jan 24:awae024. doi: 10.1093.
    >> Share

  3. BAGNATO F, Sati P, Hemond CC, Elliott C, et al
    Imaging chronic active lesions in multiple sclerosis: a consensus statement.
    Brain. 2024 Jan 16:awae013. doi: 10.1093.
    >> Share

  4. SCHWAB N
    Transcriptomics reveals CSF cellular composition in multiple sclerosis but detects no viral RNA.
    Brain. 2024 Jan 5:awae006. doi: 10.1093.
    >> Share

  5. QIN C, Chen M, Dong MH, Yang S, et al
    Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders.
    Brain. 2024;147:163-176.
    >> Share

  6. JAMANN H, Desu HL, Cui QL, Halaweh A, et al
    ALCAM on human oligodendrocytes mediates CD4 T cell adhesion.
    Brain. 2024;147:147-162.
    >> Share

    December 2023
  7. MARZIALI LN, Hwang Y, Palmisano M, Cuenda A, et al
    p38gamma MAPK delays myelination and remyelination and is abundant in multiple sclerosis lesions.
    Brain. 2023 Dec 21:awad421. doi: 10.1093.
    >> Share

  8. CALLEGARI I, Oechtering J, Schneider M, Perriot S, et al
    Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5.
    Brain. 2023 Dec 20:awad424. doi: 10.1093.
    >> Share

  9. CREE BAC
    Herpes viral infection and the multiple sclerosis prodrome: is HHV-6A infection a second hit?
    Brain. 2023 Dec 18:awad418. doi: 10.1093.
    >> Share

  10. CLEAVER J, Jeffery K, Klenerman P, Lim M, et al
    The immunobiology of herpes simplex virus encephalitis and post-viral autoimmunity.
    Brain. 2023 Dec 13:awad419. doi: 10.1093.
    >> Share

  11. BUTZKUEVEN H, Ponsonby AL, Stein MS, Lucas RM, et al
    Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome.
    Brain. 2023 Dec 12:awad409. doi: 10.1093.
    >> Share

  12. BAN M, Bredikhin D, Huang Y, Bonder MJ, et al
    Expression profiling of cerebrospinal fluid identifies dysregulated antiviral mechanisms in multiple sclerosis.
    Brain. 2023 Dec 1:awad404. doi: 10.1093.
    >> Share

    November 2023
  13. KEDDIE S, Smyth D, Keh RYS, Chou MKL, et al
    Peripherin is a biomarker of axonal damage in peripheral nervous system disease.
    Brain. 2023;146:4562-4573.
    >> Share

    October 2023
  14. GRUT V, Bistrom M, Salzer J, Stridh P, et al
    Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis.
    Brain. 2023 Oct 31:awad374. doi: 10.1093.
    >> Share

  15. BERNARD HEALEY SA, Giovannoni G, Noyce A, Dobson R, et al
    Impact of multiple sclerosis risk alleles on the plasma proteome.
    Brain. 2023 Oct 18:awad363. doi: 10.1093.
    >> Share

  16. ALLEN NM, O'Rahelly M, Eymard B, Chouchane M, et al
    The emerging spectrum of fetal acetylcholine receptor antibody-related disorders (FARAD).
    Brain. 2023;146:4233-4246.
    >> Share

    September 2023
  17. MATSUMOTO Y, Kaneko K, Takahashi T, Takai Y, et al
    Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids.
    Brain. 2023;146:3938-3948.
    >> Share

    August 2023
  18. KEDDIE S, Smyth D, Keh RYS, Wieske L, et al
    Reply: Peripherin is a biomarker of axonal damage in Guillain Barre syndrome: a pathophysiological annotation.
    Brain. 2023 Aug 30:awad276. doi: 10.1093.
    >> Share

  19. FLEISCHER V, Gonzalez-Escamilla G, Pareto D, Rovira A, et al
    Prognostic value of single-subject grey matter networks in early multiple sclerosis.
    Brain. 2023 Aug 29:awad288. doi: 10.1093.
    >> Share

  20. LEYPOLDT F, Wandinger KP
    Post-herpes simplex virus encephalitis autoimmunity: more the rule than the exception.
    Brain. 2023 Aug 28:awad290. doi: 10.1093.
    >> Share

  21. BERCIANO J
    Peripherin is a biomarker of axonal damage in Guillain Barre syndrome: a pathophysiological annotation.
    Brain. 2023 Aug 17:awad277. doi: 10.1093.
    >> Share

  22. LEBRUN-FRENAY C, Okuda DT, Siva A, Landes-Chateau C, et al
    The radiologically isolated syndrome: revised diagnostic criteria.
    Brain. 2023;146:3431-3443.
    >> Share

    June 2023
  23. SHARMIN S, Roos I, Simpson-Yap S, Malpas C, et al
    The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
    Brain. 2023 Jun 27:awad218. doi: 10.1093.
    >> Share

  24. HENRIET E, Martin EM, Jubin P, Langui D, et al
    Monitoring recovery after CNS demyelination, a novel tool to de-risk pro-remyelinating strategies.
    Brain. 2023;146:2453-2463.
    >> Share

  25. CORTESE R, Battaglini M, Prados F, Bianchi A, et al
    Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.
    Brain. 2023;146:2489-2501.
    >> Share

    April 2023
  26. CHARABATI M, Zandee S, Fournier AP, Tastet O, et al
    MCAM+ brain endothelial cells contribute to neuroinflammation by recruiting pathogenic CD4+ T lymphocytes.
    Brain. 2023;146:1483-1495.
    >> Share

  27. GUO Y, Lennon VA
    A distinctive IgG-mediated pathogenesis for primary progressive multiple sclerosis?
    Brain. 2023 Apr 3:awad107. doi: 10.1093.
    >> Share

    March 2023
  28. LIN J, Zhou J, Xu Y
    Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis.
    Brain. 2023 Mar 2:awad070. doi: 10.1093.
    >> Share

    February 2023
  29. WONG JK, Lin J, Kung NJ, Tse AL, et al
    Cerebrospinal fluid immunoglobulins in primary progressive multiple sclerosis are pathogenic.
    Brain. 2023 Feb 3:awad031. doi: 10.1093.
    >> Share

    December 2022
  30. NIJ BIJVANK JA, Hof SN, Prouskas SE, Schoonheim MM, et al
    A novel eye-movement impairment in multiple sclerosis indicating wide-spread cortical damage.
    Brain. 2022 Dec 20:awac474. doi: 10.1093.
    >> Share

  31. JAMES BATES RE, Browne E, Schalks R, Jacobs H, et al
    Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration.
    Brain. 2022;145:4287-4307.
    >> Share

  32. PISA M, Pansieri J, Yee S, Ruiz J, et al
    Anterior optic pathway pathology in CNS demyelinating diseases.
    Brain. 2022;145:4308-4319.
    >> Share

    November 2022
  33. JOKUBAITIS VG, Campagna MP, Ibrahim O, Stankovich J, et al
    Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity.
    Brain. 2022 Nov 30:awac449. doi: 10.1093.
    >> Share

  34. GAUTHIER SA
    Location, location, location: myelin repair and proximity to ventricular CSF in multiple sclerosis.
    Brain. 2022 Nov 30:awac448. doi: 10.1093.
    >> Share

  35. ARRAMBIDE G, Espejo C, Carbonell-Mirabent P, Dieli-Crimi R, et al
    The kappa free light chain index and oligoclonal bands have a similar role in the McDonald criteria.
    Brain. 2022;145:3931-3942.
    >> Share

  36. CORDANO C, Sin JH, Timmons G, Yiu HH, et al
    Validating visual evoked potentials as a preclinical, quantitative biomarker for remyelination efficacy.
    Brain. 2022;145:3943-3952.
    >> Share

  37. LIN X, Yang Y, Gresle M, Cuellar-Partida G, et al
    Novel plasma and brain proteins that are implicated in multiple sclerosis.
    Brain. 2022 Nov 8. pii: 6809197. doi: 10.1093.
    >> Share

  38. GARTON T, Gill AJ, Calabresi PA
    Distinct mechanisms of oligodendrocyte injury inform therapeutic interventions in multiple sclerosis.
    Brain. 2022 Nov 3. pii: 6794531. doi: 10.1093.
    >> Share

  39. ROSTGAARD K, Nielsen NM, Melbye M, Frisch M, et al
    Siblings reduce multiple sclerosis risk by preventing delayed primary Epstein-Barr virus infection.
    Brain. 2022 Nov 1. pii: 6783238. doi: 10.1093.
    >> Share

    September 2022
  40. VAN STEENHOVEN RW, Titulaer MJ
    Seronegative autoimmune encephalitis: exploring the unknown.
    Brain. 2022 Sep 16. pii: 6701799. doi: 10.1093.
    >> Share

  41. TONIETTO M, Poirion E, Lazzarotto A, Ricigliano V, et al
    Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration.
    Brain. 2022 Sep 13. pii: 6696508. doi: 10.1093.
    >> Share

  42. TEPAVCEVIC V, Lubetzki C
    Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?
    Brain. 2022 Sep 12. pii: 6696052. doi: 10.1093.
    >> Share

    August 2022
  43. AL-DIWANI A, Theorell J, Damato V, Bull J, et al
    Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis.
    Brain. 2022;145:2742-2754.
    >> Share

    July 2022
  44. GOVERT F, Abrante L, Becktepe J, Balint B, et al
    Distinct movement disorders in contactin-associated-protein-like-2 antibody associated autoimmune encephalitis.
    Brain. 2022 Jul 25. pii: 6649472. doi: 10.1093.
    >> Share

  45. BHARGAVA P, Hartung HP, Calabresi PA
    Contribution of B cells to cortical damage in multiple sclerosis.
    Brain. 2022 Jul 1. pii: 6623951. doi: 10.1093.
    >> Share

    June 2022
  46. DADAR M, Mahmoud S, Narayanan S, Collins DL, et al
    Diffusely abnormal white matter converts to T2 lesion volume in the absence of MRI-detectable acute inflammation.
    Brain. 2022;145:2008-2017.
    >> Share

  47. RUCK T, Barman S, Schulte-Mecklenbeck A, Pfeuffer S, et al
    Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity.
    Brain. 2022;145:1711-1725.
    >> Share

  48. BRADL M
    From astrocyte destruction to axon injury: watching lesion evolution in experimental neuromyelitis optica.
    Brain. 2022;145:1581-1583.
    >> Share

  49. HERWERTH M, Kenet S, Schifferer M, Winkler A, et al
    A new form of axonal pathology in a spinal model of neuromyelitis optica.
    Brain. 2022;145:1726-1742.
    >> Share

  50. ADRICHEM ME, Lucke IM, Vrancken AFJE, Goedee HS, et al
    Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
    Brain. 2022;145:1641-1652.
    >> Share

  51. COLES A
    Campath, clones and the cause of autoimmunity.
    Brain. 2022;145:1579-1580.
    >> Share

  52. MADSEN MAJ, Wiggermann V, Marques MFM, Lundell H, et al
    Linking lesions in sensorimotor cortex to contralateral hand function in multiple sclerosis: a 7 T MRI study.
    Brain. 2022 Jun 2. pii: 6599027. doi: 10.1093.
    >> Share

    May 2022
  53. GUO Y, Lennon VA, Parisi JE, Popescu B, et al
    Spectrum of sublytic astrocytopathy in neuromyelitis optica.
    Brain. 2022;145:1379-1390.
    >> Share

  54. BERNARD-VALNET R, Frieser D, Nguyen XH, Khajavi L, et al
    Influenza vaccination induces autoimmunity against orexinergic neurons in a mouse model for narcolepsy.
    Brain. 2022 May 13. pii: 6581499. doi: 10.1093.
    >> Share

  55. EISSMAN JM, Dumitrescu L, Mahoney ER, Smith AN, et al
    Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease.
    Brain. 2022 May 13. pii: 6585174. doi: 10.1093.
    >> Share

  56. LEE WJ, Lee HS, Kim DY, Lee HS, et al
    Seronegative autoimmune encephalitis: clinical characteristics and factors associated with outcomes.
    Brain. 2022 May 5. pii: 6580901. doi: 10.1093.
    >> Share

    April 2022
  57. CORNBLATH DR, van Doorn PA, Hartung HP, Merkies ISJ, et al
    Randomized trial of three IVIg doses for treating chronic inflammatory demyelinating polyneuropathy.
    Brain. 2022;145:887-896.
    >> Share

    March 2022
  58. STRIPPEL C, Herrera-Rivero M, Wendorff M, Tietz AK, et al
    A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies.
    Brain. 2022 Mar 28. pii: 6555060. doi: 10.1093.
    >> Share

  59. PORTACCIO E, Bellinvia A, Fonderico M, Pasto L, et al
    Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study.
    Brain. 2022 Mar 24. pii: 6553893. doi: 10.1093.
    >> Share

  60. SHAMS H, Shao X, Santaniello A, Kirkish G, et al
    Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans.
    Brain. 2022 Mar 7. pii: 6542574. doi: 10.1093.
    >> Share

    February 2022
  61. PERNIN F, Luo J, Cui QL, Blain M, et al
    Diverse injury responses of human oligodendrocyte to mediators implicated in multiple sclerosis.
    Brain. 2022 Feb 24. pii: 6535861. doi: 10.1093.
    >> Share

  62. KEH RYS, Scanlon S, Datta-Nemdharry P, Donegan K, et al
    COVID-19 vaccination and Guillain-Barre syndrome: analyses using the National Immunoglobulin Database.
    Brain. 2022 Feb 18. pii: 6532037. doi: 10.1093.
    >> Share

  63. LUBLIN FD, Haring DA, Ganjgahi H, Ocampo A, et al
    How patients with multiple sclerosis acquire disability.
    Brain. 2022 Feb 1. pii: 6519354. doi: 10.1093.
    >> Share

    January 2022
  64. NISHIHARA H, Perriot S, Gastfriend BD, Steinfort M, et al
    Intrinsic blood-brain barrier dysfunction contributes to multiple sclerosis pathogenesis.
    Brain. 2022 Jan 27. pii: 6516047. doi: 10.1093.
    >> Share

    December 2021
  65. GREEN AJ
    Socioeconomic disadvantage in multiple sclerosis: does inequality act on the substrate for disability?
    Brain. 2021 Dec 20. pii: 6470562. doi: 10.1093.
    >> Share

  66. CAROTENUTO A, Cacciaguerra L, Pagani E, Preziosa P, et al
    Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability.
    Brain. 2021 Dec 17. pii: 6469024. doi: 10.1093.
    >> Share

  67. NTRANOS A, Park HJ, Wentling M, Tolstikov V, et al
    Bacterial neurotoxic metabolites in multiple sclerosis cerebrospinal fluid and plasma.
    Brain. 2021 Dec 11. pii: 6459638. doi: 10.1093.
    >> Share

    November 2021
  68. LIEBMANN M, Korn L, Janoschka C, Albrecht S, et al
    Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunity.
    Brain. 2021;144:3126-3141.
    >> Share

  69. ZIEGLER D, Bonhof GJ, Strom A, Strassburger K, et al
    Progression and regression of nerve fibre pathology and dysfunction early in diabetes over 5 years.
    Brain. 2021;144:3251-3263.
    >> Share

    October 2021
  70. VASILEIOU ES, Filippatou AG, Pimentel Maldonado D, Kalaitzidis G, et al
    Socioeconomic disparity is associated with faster retinal neurodegeneration in multiple sclerosis.
    Brain. 2021 Oct 29. pii: 6414110. doi: 10.1093.
    >> Share

  71. RODGERS J, Friede T, Vonberg FW, Constantinescu CS, et al
    The impact of smoking cessation on multiple sclerosis disease progression.
    Brain. 2021 Oct 8. pii: 6384574. doi: 10.1093.
    >> Share

    September 2021
  72. LUIJTEN LWG, Leonhard SE, van der Eijk AA, Doets AY, et al
    Guillain-Barre syndrome after SARS-CoV-2 infection in an international prospective cohort study.
    Brain. 2021 Sep 23. pii: 6373760. doi: 10.1093.
    >> Share

  73. TAKAI Y, Misu T, Suzuki H, Takahashi T, et al
    Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders.
    Brain. 2021;144:2401-2415.
    >> Share

    August 2021
  74. NAUGHTON M, de la Fuente AG
    Autoantibodies and microglia: boon or bane?
    Brain. 2021 Aug 11. pii: 6348165. doi: 10.1093.
    >> Share

    July 2021
  75. BENALLEGUE N, Kebir H, Kapoor R, Crockett A, et al
    The hedgehog pathway suppresses neuropathogenesis in CD4 T cell-driven inflammation.
    Brain. 2021;144:1670-1683.
    >> Share

  76. JENSEN TS, Karlsson P, Gylfadottir SS, Andersen ST, et al
    Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management.
    Brain. 2021;144:1632-1645.
    >> Share

  77. MITSDOERFFER M, Di Liberto G, Dotsch S, Sie C, et al
    Corrigendum to: Formation and immunomodulatory function of meningeal B cell aggregates in progressive CNS autoimmunity.
    Brain. 2021 Jul 14. pii: 6321151. doi: 10.1093.
    >> Share

    June 2021
  78. BITTNER S, Oh J, Havrdova EK, Tintore M, et al
    The potential of serum neurofilament as biomarker for multiple sclerosis.
    Brain. 2021 Jun 28. pii: 6310737. doi: 10.1093.
    >> Share

  79. COLLORONE S, Prados F, Kanber B, Cawley NM, et al
    Brain microstructural and metabolic alterations detected in vivo at onset of the first demyelinating event.
    Brain. 2021;144:1409-1421.
    >> Share

  80. HAIDER L, Prados F, Chung K, Goodkin O, et al
    Cortical involvement determines impairment 30 years after a clinically isolated syndrome.
    Brain. 2021;144:1384-1395.
    >> Share

  81. PELLERIN K, Rubino SJ, Burns JC, Smith BA, et al
    MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response.
    Brain. 2021 Jun 18. pii: 6305830. doi: 10.1093.
    >> Share

    May 2021
  82. GRANZIERA C, Wuerfel J, Barkhof F, Calabrese M, et al
    Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis.
    Brain. 2021 May 10. pii: 6273092. doi: 10.1093.
    >> Share

  83. VAN DOORN PA, Hadden RDM, Van den Bergh PYK
    Elucidating autoimmune nodopathies and the CIDP spectrum.
    Brain. 2021;144:1043-1045.
    >> Share

  84. PASCUAL-GONI E, Fehmi J, Lleixa C, Martin-Aguilar L, et al
    Antibodies to the Caspr1/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy.
    Brain. 2021;144:1183-1196.
    >> Share

    April 2021
  85. FLECK AK, Hucke S, Teipel F, Eschborn M, et al
    Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity.
    Brain. 2021 Apr 26. pii: 6252379. doi: 10.1093.
    >> Share

  86. GHORBANI S, Yong VW
    The extracellular matrix as modifier of neuroinflammation and remyelination in multiple sclerosis.
    Brain. 2021 Apr 23. pii: 6247173. doi: 10.1093.
    >> Share

  87. PARDINI M, Brown JWL, Magliozzi R, Reynolds R, et al
    Surface-in pathology in multiple sclerosis: a new view on pathogenesis?
    Brain. 2021 Apr 20. pii: 6238675. doi: 10.1093.
    >> Share

  88. PISA M, Croese T, Dalla Costa G, Guerrieri S, et al
    Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes.
    Brain. 2021 Apr 8. pii: 6215108. doi: 10.1093.
    >> Share

  89. LUCCHESE G, Floel A
    Guillain-Barre syndrome, SARS-CoV-2 and molecular mimicry.
    Brain. 2021 Apr 3. pii: 6209729. doi: 10.1093.
    >> Share

  90. LUNN MP, Carr AC, Keddie S, Pakpoor J, et al
    Reply: Guillain-Barre syndrome, SARS-CoV-2 and molecular mimicry and Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barre syndrome and Unclear association between COVID-19 and Guillain-Barre syndrome and Currently avai
    Brain. 2021 Apr 3. pii: 6209732. doi: 10.1093.
    >> Share

  91. FOSCHI M, D'Anna L, Abdelhak A, Mayer B, et al
    Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barre syndrome.
    Brain. 2021 Apr 3. pii: 6209733. doi: 10.1093.
    >> Share

  92. GONZALEZ DEL CASTILLO J, Porta-Etessam J, Miro O
    Currently available data regarding the potential association between COVID-19 and Guillain-Barre syndrome.
    Brain. 2021 Apr 3. pii: 6209731. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016